ARDX Stock Analysis: Buy, Sell, or Hold?
ARDX - Ardelyx, Inc.
$3.89
-0.01 (-0.26%)
▼
5d:
-4.19%
30d:
-24.17%
90d:
-38.74%
HOLD
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When ARDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ARDX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ARDX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$8.23
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.11
23.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ARDX is currently trading at $3.89, which is considered oversold relative to its 30-day fair value range of $4.13 to $5.20. From a valuation perspective, the stock is trading at a discount (Forward PE: 12.2) compared to its historical average (18.4). Remarkably, the market is currently pricing in an annual earnings decline of 12.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ARDX is in a strong uptrend. The price is currently testing key support at $3.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ARDX scores 82/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $13.00 (+234.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ARDX is in a strong uptrend. The price is currently testing key support at $3.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ARDX scores 82/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $13.00 (+234.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.13 -
$5.20
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
90.5%
Protect Your Profits
Holding ARDX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (82/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 234.2% below Wall St target ($13.00)
- CAUTION: Bottoming setup, but lagging the sector by 23% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$4.13 -
$5.20
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.86
Resistance Level
$4.12
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.19
Wall Street Target
$13.00
(+234.2%)
Revenue Growth (YoY)
23.8%
Profit Margin
-12.3%
Valuation Discount vs History
-12.9% cheaper
PE vs Historical
12.2 vs 18.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-12.9%
(market-implied from PE analysis)
1-Year Target
$3.50
(-10%)
2-Year Target
$3.15
(-19%)
3-Year Target
$2.84
(-27%)
3-Yr Target (if PE normalizes)
(PE: 12→18)
$4.28
(+10%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.2 to 18.4
Stabilization Target:
$5.87
(+50.9%)
PE Expansion Potential:
+50.9%
Share & Embed Analysis
Last updated: August 23, 2026 11:49 PM ET
Data refreshes hourly during market hours. Next update: 12:49 AM
Data refreshes hourly during market hours. Next update: 12:49 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Raab
SELL
41666 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 42 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 66 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 50 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 52 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$127 | 41 HOLD |
Advanced ARDX Option Strategies
Professional options setups generated by AI based on today's ARDX price and gamma walls.
